858124-04-6

Basic information

• Product Name: ethyl 3-(chloromethyl)-4-methoxybenzoate
• Synonyms: ethyl 3-(chloromethyl)-4-methoxybenzoate
• CAS NO: 858124-04-6
• Molecular Weight: 228.675
• Mol File: 858124-04-6.mol
• Article Data: 3

Chemical Properties

• CAS DataBase Reference: ethyl 3-(chloromethyl)-4-methoxybenzoate(CAS DataBase Reference)
• NIST Chemistry Reference: ethyl 3-(chloromethyl)-4-methoxybenzoate(858124-04-6)
• EPA Substance Registry System: ethyl 3-(chloromethyl)-4-methoxybenzoate(858124-04-6)

Safety Data

• Hazardous Substances Data: 858124-04-6(Hazardous Substances Data)

Upstream product

• 15454-33-8 chloromethanol 
• 94-30-4 ethyl 4-methoxybenzoate 
• 107-30-2 chloromethyl methyl ether 

Downstream Products

• 1360060-10-1 ethyl 3-(diethoxyphosphorylmethyl)-4-methoxybenzoate 
• 1187941-25-8 C₁₂H₁₃NO₃ 
• 1187941-46-3 C₁₁H₁₃N₃O₃ 
• 1360060-15-6 ethyl 3-[(4-chlorophenoxy)methyl]-4-methoxybenzoate 
• 438221-04-6 3-[(4-chlorophenoxy)methyl]-4-methoxybenzoic acid 
• 438218-99-6 3-[(4-chloro-3-methylphenoxymethyl)]-4-methoxybenzoic acid 
• 1360060-33-8 3-[(E)-2-(4-chloro-2-fluorophenyl)vinyl]-4-methoxybenzamide 
• 1360060-31-6 3-[(E)-2-(3,4-dichlorophenyl)vinyl]-4-methoxybenzamide 
• 1360060-29-2 3-[(E)-2-(2-chlorophenyl)vinyl]-4-methoxybenzamide 
• 1360060-27-0 4-methoxy-3-[(E)-2-[2-(trifluoromethoxy)phenyl]vinyl]benzamide 
• 1360060-26-9 4-methoxy-3-[(E)-2-(2-methoxyphenyl)vinyl]benzamide 
• 1360060-25-8 4-methoxy-3-[(E)-2-(2-tolyl)vinyl]benzamide 
• 1360060-24-7 3-[(E)-2-(3-cyanophenyl)vinyl]-4-methoxybenzamide 
• 1360060-23-6 3-[(E)-2-(3-chlorophenyl)vinyl]-4-methoxybenzamide 

Relevant articles and documents

Angiogenesis inhibitors identified by cell-based high-throughput screening: Synthesis, structure-activity relationships and biological evaluation of 3-[(E)-styryl]benzamides that specifically inhibit endothelial cell proliferation

Proliferation of endothelial cells is critical for angiogenesis. We report orally available, in vivo active antiangiogenic agents which specifically inhibit endothelial cell proliferation. After identifying human umbilical vein endothelial cell (HUVEC) pr

BENZAMIDE DERIVATIVE

To provide compounds which have high angiogenesis inhibiting activity, and are useful as agents for effective treatment and prevention of diseases involving pathologic angiogenesis, for example, cancer and cancer metastasis, methods for producing the comp